np137
Showing 1 - 5 of 5
Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)
Recruiting
- Acute Myeloid Leukemia Refractory
- NP137
- +2 more
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2023
Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- NP137
- +4 more
- (no location specified)
Sep 23, 2022
Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- NP137
- +2 more
- (no location specified)
Sep 23, 2022
Advanced Solid Tumors, Metastatic Solid Tumors Trial in Lyon (NP137, anti-PD-1/PD-L1)
Recruiting
- Advanced Solid Tumors
- Metastatic Solid Tumors
- NP137
- anti-PD-1/PD-L1
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2022
Endometrial Carcinoma, Cervix Carcinoma Trial in France (NP137, Pembrolizumab, Paclitaxel)
Recruiting
- Endometrial Carcinoma
- Cervix Carcinoma
- NP137
- +3 more
-
Bordeaux, France
- +11 more
Jun 7, 2022